Finanzen von Balchem Corporation (BCPC)BCPCBalchem Corporation

Balchem Corporation (BCPC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product Sales Revenue, accounting for 99.8% of total sales, equivalent to $283.36M. Another important revenue stream is Royalty. Understanding this composition is critical for investors evaluating how BCPC navigates market cycles within the Specialty Chemicals industry.

Evaluating the bottom line, Balchem Corporation maintains a gross margin of 36.51%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 20.85%, while the net margin is 15.71%. These profitability ratios, combined with a Return on Equity (ROE) of 12.79%, provide a clear picture of how effectively BCPC converts its operational activities into shareholder value.

In the context of the broader market, BCPC competes directly with industry leaders such as SXT and INGR. With a market capitalization of $5.69B, it holds a significant position in the sector. When comparing efficiency, BCPC's gross margin of 36.51% stands against SXT's 37.40% and INGR's 23.03%. Such benchmarking helps identify whether Balchem Corporation is trading at a premium or discount relative to its financial performance.

Balchem has shown consistent revenue growth, with Q2 2026 revenues of $284 million, an 11.2% year-over-year increase. The gross margin for Q2 is 36.5%, reflecting strong profitability.